Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DDP225 in Patients With Chronic Functional Vomiting

NCT00252993 is registered in ClinicalTrials.gov with Dynogen Pharmaceuticals as lead sponsor.

NCT NCT00252993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DDP225 in Patients With Chronic Functional Vomiting
Lead sponsor
Dynogen Pharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2005
Completion date
March 31, 2006
Enrollment
30
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

vomiting